Showing 1761-1770 of 4064 results for "".
Beyond the Flare: Choosing the Right Systemic in Moderate-to-Severe Atopic Dermatitis
https://reachmd.com/series/dermatology-hub-neuroimmune-network/beyond-the-flare-choosing-the-right-systemic-in-moderate-to-severe-atopic-dermatitis/39728/Androgen Receptor Emerges as a Marker of Differentiation in Endometrial Cancer
https://reachmd.com/programs/project-oncology/androgen-receptor-emerges-as-a-marker-of-differentiation-in-endometrial-cancer/35511/Read about emerging data positioning the androgen receptor as a complementary biomarker for stratifying hormone-responsive endometrial cancer.Early-Onset Endometrial Cancer: Bridging the Gap Between Age and Outcome
https://reachmd.com/programs/project-oncology/early-onset-endometrial-cancer-bridging-the-gap-between-age-and-outcome/35510/Explore how a novel predictive model outperforms TNM and SEER staging in guiding early-onset endometrial cancer management and improving individualized survival predictions.Newborn Gene Sequencing: Expanding Early Detection of Treatable Diseases
https://reachmd.com/programs/medical-industry-feature/newborn-gene-sequencing-expanding-early-detection-of-treatable-diseases/29916/Tune in to hear from a variety of pediatric specialists who share perspectives on the GUARDIAN study, which explored the role of genetic testing in newborns.Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
https://reachmd.com/programs/neurofrontiers/safety-outcomes-in-ms-clinical-trials-examining-comorbidities-and-adverse-events/32705/Learn how comorbidities are related to adverse events and early discontinuation in phase III multiple sclerosis trials.Assessing the Effectiveness of Intravenous Ertapenem in HS Patients
https://reachmd.com/programs/dermconsult/assessing-the-effectiveness-of-intravenous-ertapenem-in-hs-patients/18110/Read more to explore the optimal course duration, efficacy, and patient satisfaction associated with intravenous ertapenem for HS.Overcoming Obesity: Insights from the SURMOUNT-4 Trial
https://reachmd.com/programs/diabetes-discourse/overcoming-obesity-insights-from-the-surmount-4-trial/17886/Tune in to learn about how a study focusing on tirzepatide helped with the maintenance of weight loss in adults with obesity.The Increasing Incidence of IBD and the Use of Biosimilars
https://reachmd.com/programs/gi-insights/increasing-incidence-of-ibd-and-the-use-of-biosimilars/15978/Infliximab and adalimumab are the two most commonly used biologics in IBD treatment. Learn more.Treating Tricuspid Valve Regurgitation With Novel Replacement Device
https://reachmd.com/programs/heart-matters/treating-tricuspid-valve-regurgitation-with-novel-replacement-device/15268/What can clinicians learn from this first-ever procedure that implanted a novel transcatheter tricuspid valve replacement device?Onboarding: It Is Your Responsibility
https://reachmd.com/topics/practice-development/onboarding-its-your-sopportunitys-responsibility/35209/It’s hard enough to find good talent. Here’s a 90-day guide to laying the foundation for long-term success.